BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 11795118)

  • 1. [Vascular complications of diabetes: is there a glycemic threshold?].
    Isnard F; Eschwège E
    Rev Prat; 2001 Oct; 51(16):1759-64. PubMed ID: 11795118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.
    Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glycaemic control and complications of diabetes: what about?].
    Bouhanick B; Barigou M; Kantambadouno JB; Chamontin B
    Presse Med; 2013 May; 42(5):849-54. PubMed ID: 23540378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic variability in the development of cardiovascular complications in diabetes.
    Nusca A; Tuccinardi D; Albano M; Cavallaro C; Ricottini E; Manfrini S; Pozzilli P; Di Sciascio G
    Diabetes Metab Res Rev; 2018 Nov; 34(8):e3047. PubMed ID: 30028067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tissular toxicity of glucose and therapeutic perspectives].
    Larger E; Marre M
    Rev Prat; 2001 Oct; 51(16):1765-8. PubMed ID: 11795119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses.
    Liu QZ; Pettitt DJ; Hanson RL; Charles MA; Klein R; Bennett PH; Knowler WC
    Diabetologia; 1993 May; 36(5):428-32. PubMed ID: 8314447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood glucose control and microvascular and macrovascular complications in diabetes.
    Hanssen KF
    Diabetes; 1997 Sep; 46 Suppl 2():S101-3. PubMed ID: 9285509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Continuing care of patients with cardiovascular risk in general practice: diabetic patients and their care].
    Ilyés I; Jancsó Z; Kovács E; Márton H; Simay A
    Orv Hetil; 2005 Dec; 146(51):2581-8. PubMed ID: 16468612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes.
    Gabir MM; Hanson RL; Dabelea D; Imperatore G; Roumain J; Bennett PH; Knowler WC
    Diabetes Care; 2000 Aug; 23(8):1113-8. PubMed ID: 10937507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance, pathogenesis, and management of postprandial hyperglycemia.
    Gerich JE
    Arch Intern Med; 2003 Jun; 163(11):1306-16. PubMed ID: 12796066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.
    Abraira C; Duckworth W; McCarren M; Emanuele N; Arca D; Reda D; Henderson W;
    J Diabetes Complications; 2003; 17(6):314-22. PubMed ID: 14583175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited.
    Engelgau MM; Thompson TJ; Herman WH; Boyle JP; Aubert RE; Kenny SJ; Badran A; Sous ES; Ali MA
    Diabetes Care; 1997 May; 20(5):785-91. PubMed ID: 9135943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Moram CBM; Salles GF
    Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes.
    Aso Y; Inukai T; Tayama K; Takemura Y
    Acta Diabetol; 2000; 37(2):87-92. PubMed ID: 11194933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes.
    McCance DR; Hanson RL; Charles MA; Jacobsson LT; Pettitt DJ; Bennett PH; Knowler WC
    BMJ; 1994 May; 308(6940):1323-8. PubMed ID: 8019217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic complications. The importance of glucose control.
    Skyler JS
    Endocrinol Metab Clin North Am; 1996 Jun; 25(2):243-54. PubMed ID: 8799699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperglycaemia and diabetes mellitus.
    Jarrett RJ; Keen H
    Lancet; 1976 Nov; 2(7993):1009-12. PubMed ID: 62224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications.
    Ceriello A
    Diabetologia; 2003 Mar; 46 Suppl 1():M9-16. PubMed ID: 12652353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intensive glucose control in type 2 diabetes is beneficial].
    Nilsson PM; Attvall S
    Lakartidningen; 2009 Sep 2-8; 106(36):2198. PubMed ID: 19817174
    [No Abstract]   [Full Text] [Related]  

  • 20. The science of hypoglycemia in patients with diabetes.
    Oyer DS
    Curr Diabetes Rev; 2013 May; 9(3):195-208. PubMed ID: 23506375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.